F13S (p.Phe13Ser) variant of CASQ2 (Calsequestrin-2)

F13S (p.Phe13Ser) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.38 / 1. The record also includes population frequency data and structural context.

F13S (p.Phe13Ser) variant details